| |
| |
|
| Insider
Information: |
Reeve Emma |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
19,668 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$409,024 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,668 |
|
|
| Total
Value |
$409,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -87.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PAREXEL International |
PRXL |
Corp. VP & Interim CFO |
2016-12-07 |
8,468 |
|
0 |
Premium* |
|
|
Constellation Pharmaceuticals Inc |
CNST |
|
2021-02-22 |
0 |
2019-11-05 |
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
11,200 |
2020-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2019-11-06 |
4 |
OE |
$6.61 |
$442,781 |
D/D |
65,626 |
65,626 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2019-11-06 |
4 |
AS |
$16.31 |
$1,410,775 |
D/D |
(65,626) |
0 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-05-11 |
4 |
AS |
$49.53 |
$795,623 |
D/D |
(16,062) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-05-11 |
4 |
OE |
$6.61 |
$143,269 |
D/D |
16,062 |
16,062 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-05-08 |
4 |
OE |
$8.04 |
$125,467 |
D/D |
12,741 |
12,741 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-05-08 |
4 |
AS |
$49.53 |
$631,055 |
D/D |
(12,741) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-11 |
4 |
S |
$35.04 |
$302,816 |
D/D |
(8,642) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-11 |
4 |
OE |
$7.60 |
$66,308 |
D/D |
8,642 |
1,430 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-05-22 |
4 |
AS |
$59.52 |
$423,630 |
D/D |
(7,116) |
7,200 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-05-22 |
4 |
OE |
$33.02 |
$237,484 |
D/D |
7,116 |
11,148 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-22 |
4 |
OE |
$8.04 |
$50,330 |
D/D |
6,260 |
6,260 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-22 |
4 |
AS |
$37.60 |
$235,373 |
D/D |
(6,260) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-12-21 |
4 |
OE |
$6.61 |
$38,975 |
D/D |
5,720 |
5,720 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-12-21 |
4 |
AS |
$35.11 |
$200,805 |
D/D |
(5,720) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-13 |
4 |
AS |
$35.06 |
$193,539 |
D/D |
(5,521) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-13 |
4 |
OE |
$8.04 |
$44,389 |
D/D |
5,521 |
5,521 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-04-21 |
4 |
AS |
$55.04 |
$238,258 |
D/D |
(4,328) |
7,200 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-19 |
4 |
OE |
$8.04 |
$32,240 |
D/D |
4,010 |
4,010 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-19 |
4 |
AS |
$37.71 |
$151,218 |
D/D |
(4,010) |
0 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
11,528 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
11,200 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,200 |
7,528 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-05-23 |
4 |
AS |
$59.52 |
$157,885 |
D/D |
(2,652) |
7,200 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-05-23 |
4 |
OE |
$33.02 |
$88,520 |
D/D |
2,652 |
8,602 |
0 |
- |
|
| PRXL |
PAREXEL International |
Corp. VP & Interim CFO |
• • – |
2016-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,348 |
8,468 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
